What is the ACCF/AHA/HRS recommendation for the use of dabigatran in patients with atrial fibrillation and mechanical valves?

Updated: May 07, 2019
  • Author: Xiushui (Mike) Ren, MD; Chief Editor: Terrence X O'Brien, MD, MS, FACC  more...
  • Print

In the 2014 joint guidelines on the management of atrial fibrillation (AF), the American College of Cardiology Foundation, American Heart Association, and Heart Rhythm Society (ACCF/AHA/HRS) recommended against the use of dabigatran in patients with AF and a mechanical heart valve. (Class III) [55]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!